Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: A randomised placebo-controlled study

Primary Care Respiratory Journal

Volumn 21, Issue 3, 2012, Pages 267-275

  Keith, Paul K ^a   Dymek, Andrzej ^b   Pfaar, Oliver ^c   Fokkens, Wytske ^d   Kirby, Suyong Yun ^e   Wu, Wei ^e   Garris, Cindy ^e   Topors, Nazli ^f   Lee, Laurie A ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b Centrum Medyczne Lucyna Andrzej Dymek NZOZ SC   (Poland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e GLAXOSMITHKLINE   (United States)

^f GLAXOSMITHKLINE   (Canada)

Author keywords

Acute rhinosinusitis; Intranasal corticosteroid; Monotherapy; Placebo controlled; Randomised; Symptomatic therapy

Indexed keywords

ANTIBIOTIC AGENT; FLUTICASONE FUROATE; PLACEBO;

ACUTE RHINOSINUSITIS; ADOLESCENT; ADULT; ARTICLE; BACTERIAL SINUSITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FACE PAIN; FEMALE; FULMINANT BACTERIAL SINUSITIS; HUMAN; MAJOR CLINICAL STUDY; MAJOR SYMPTOM SCORE; MALE; MONOTHERAPY; MUCOSAL BLEEDING; MULTICENTER STUDY; NOSE DISEASE; NOSE OBSTRUCTION; POSTNASAL DRIP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINUS HEADACHE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANDROSTADIENES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NASAL SPRAYS; RHINITIS; SINUSITIS;

EID: 84866381536     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00039     Document Type: Article

References (17)

1. Fokkens W, Lund V, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps Group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 2007;(Suppl 20):1-136.
2. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007;137(3 Suppl):S1-31. http://dx.doi.org/10.1016/j.otohns.2007.06.726
3. Mygind N, Prytz S, Sorensen H, Pedersen CB. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. I. Treatment and rationale. Acta Otolaryngol 1976;82(3-4):252-5. http://dx.doi.org/10.3109/00016487609120897
4. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997;78(6):598-601. http://dx.doi.org/10.1016/S1081-1206(10)63223-1
5. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW Jr, Califf RM, Simel DL, Ceftin and Flonase for Sinusitis (CAFFS) Investigators. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 2001;286(24):3097-105. http://dx.doi.org/10.1001/jama.286.24.3097
6. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92(6):812-23. http://dx.doi.org/10.1016/0091-6749(93)90058-N
7. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol 2000;106(4):630-7. http://dx.doi.org/10.1067/mai.2000.109056
8. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95. http://dx.doi.org/10.1016/j.jaci.2005.08.044
9. Merck Canada Inc. Nasonex mometasone furoate monohydrate aqueous nasal spray product monograph. 4 February 2011. Search product, Nasonex, on Health Canada Drug Product Database: http://webprod.hc-sc.gc.ca/dpd-bdpp/newSearchnouvelleRecherche. do?lang=eng
10. Rosenblut A, Bardin PG, Muller B, et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007;62(9):1071-7. http://dx.doi.org/10.1111/j.1398-9995.2007.01521.x
11. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126(1):41-7. http://dx.doi.org/10.1067/mhn.2002.121022
12. Ryan D. Management of acute rhinosinusitis in primary care: changing paradigms and the emerging role of intranasal corticosteroids. Prim Care Respir J 2008;17(3):148-55. http://dx.doi.org/10.3132/pcrj.2008.00050
13. Snow V, Mottur-Pilson C, Hickner JM, American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine, Centers for Disease Control, Infectious Diseases Society of America. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001;134(6):495-7.
14. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008;(2):CD000243.
15. Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev 2007;(2):CD005149.
16. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA 2007;298(21):2487-96. http://dx.doi.org/10.1001/jama.298.21.2487
17. Salter M, Biggadike K, Mathews JL, et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007;293(3):L660-7. http://dx.doi.org/10.1152/ajplung.00108.2007